Nobel Prize winner Stanley Prusiner is closing in on better treatments for Alzheimer's, Parkinson's and other brain diseases, and an unlikely new partnership will get him there faster.
April 17, 2014
April 03, 2014
Daiichi Sankyo and UCSF have established a drug-discovery collaboration focused on developing novel therapeutics and molecular diagnostics for multiple neurodegenerative diseases.
February 26, 2014
Researchers worldwide will now have access to genetic data linked to medical information on a diverse group of more than 78,000 people, enabling investigations into many diseases and conditions.
January 13, 2014
Geneticists from Ohio, California and Japan used stem cells to correct a defective “ring chromosome” with a normal chromosome. Such therapy has the promise to correct chromosome abnormalities that give rise to birth defects, mental disabilities and growth limitations.
January 09, 2014
UCSF and Quest Diagnostics, the world's leading provider of diagnostic information services, have formed a collaboration to accelerate the translation of biomedical research into advanced diagnostics in the field of precision medicine.
December 11, 2013
The nation’s top scientists will gather at UCSF to discuss the latest in research discovery at a special symposium honoring the 2013 and 2014 Breakthrough Prize in Life Sciences Award recipients on Friday, Dec. 13.
August 19, 2013
A natural form of sugar could offer a noninvasive way to precisely image tumors and determine whether cancer medication is effective using new technology developed at UCSF in collaboration with GE Healthcare.
June 03, 2013
Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) and the University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center today announced the formation of the Oncology Innovation Alliance (OIA), a public-private partnership focusing on the discovery and development of novel therapies and their potential role in treating various types of hematologic cancers and solid tumors.
March 21, 2013
An innovative project to develop a potential therapy to treat a wide range of cancers has won a major UC San Francisco award that aims to drive promising early-stage research through the complex process of translating ideas into patient benefit.
December 13, 2011
UCSF Chancellor Susan Desmond-Hellmann, MD, former president for product development at Genentech, is featured in a video interview for BioCentury Publications Inc., a major biopharmaceutical news media source, which first aired online on Dec. 11.